scispace - formally typeset
S

Sara Castiglia

Researcher at Boston Children's Hospital

Publications -  21
Citations -  896

Sara Castiglia is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Mesenchymal stem cell & Reperfusion injury. The author has an hindex of 13, co-authored 20 publications receiving 801 citations. Previous affiliations of Sara Castiglia include University of Turin.

Papers
More filters
Journal ArticleDOI

Generation of endogenous hydrogen sulfide by cystathionine γ -lyase limits renal ischemia/reperfusion injury and dysfunction

TL;DR: The findings suggest that the synthesis of endogenous hydrogen sulfide by CSE is essential to protect the kidney against ischemia/reperfusion injury and dysfunction and aids in the recovery of renal function following ischemIA/rePerfusion.
Journal ArticleDOI

Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation.

TL;DR: This study investigated the hepatic signalling pathway activated by PPARγ activation in a non‐genetic insulin‐resistant animal model to investigate the involvement of suppressor of cytokine signalling (SOCS‐3) in the pathogenesis of insulin resistance.
Journal ArticleDOI

Insulin Reduces Cerebral Ischemia/Reperfusion Injury in the Hippocampus of Diabetic Rats: A Role for Glycogen Synthase Kinase-3β

TL;DR: It is proposed that the inhibitory effect on the activity of GSK-3β contributes to the protective effect of insulin independently of any effects on blood glucose.
Journal ArticleDOI

Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock.

TL;DR: In this paper, the role of PPAR-β/δ in sepsis was investigated in murine models of LPS-induced organ injury and dysfunction and cecal ligation and puncture (CLP) induced polymicrobial septis.
Journal ArticleDOI

Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical Use

TL;DR: Plating whole bone marrow at a low cellular density may represent a good procedure for MSC expansion for clinical use and no differences were observed in terms of gross morphology, differentiation potential or immunophenotype.